Bone Biologics Corp — Director's Dealing 2023

Sep 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bone Biologics Corp (BBLG)
CIK: 0001419554
Period of Report: 2023-08-31

Reporting Person: Frelick Jeff (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-31	Common Stock	P	7600	$0.6605	Acquired	7704	Direct

Footnotes

F1: Includes 104 shares of vested restricted stock that were inadvertently reported in Table II at the time of grant.